Inhibitor development, safety, and efficacy of Advate® in previously untreated patients with hemophilia A in a postmarketing surveillance in Japan-Reference-Cited by-同舟云学术

Inhibitor development, safety, and efficacy of Advate® in previously untreated patients with hemophilia A in a postmarketing surveillance in Japan

Published:2018-07-24 Issue:1 Volume:109 Page:70-78
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Taki Masashi,Fukutake Katsuyuki,Matsushita Tadashi,Nogami Keiji,Shima Midori,Yoshioka Akira,Takamatsu Junki,Arai Morio,Takagi Hiroshi,Uchikawa Haruhiko,Engl Werner,Shirahata Akira

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/article/10.1007/s12185-018-2499-y/fulltext.html

Reference20 articles.

1. Franchini M, Mannucci PM. Hemophilia A in the third millennium. Blood Rev. 2013;27:179–84.

2. Rodriguez-Merchan EC, Jimenez-Yuste V, Aznar JA, Hedner U, Knobe K, Lee CA, et al. Joint protection in haemophilia. Haemophilia. 2011;17(Suppl 2):1–23.

3. Lobet S, Hermans C, Lambert C. Optimal management of hemophilic arthropathy and hematomas. J Blood Med. 2014;5:207–18.

4. Srivastava A, Brewer AK, Mauser-Bunschoten EP, Key NS, Kitchen S, Llinas A, et al. Guidelines for the management of hemophilia. Haemophilia. 2013;19:e1–47.

5. Manco-Johnson MJ, Abshire TC, Shapiro AD, Riske B, Hacker MR, Kilcoyne R, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med. 2007;357:535–44.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding the evolution of coverage policies for prophylaxis treatments of hemophilia A without inhibitors: a payer Delphi panel;Journal of Managed Care & Specialty Pharmacy;2021-04-12

2. An evaluation of the safety and efficacy of turoctocog alfa for hemophilia A;Expert Review of Hematology;2020-03-14

3. Blood, blood components, plasma, and plasma products;Side Effects of Drugs Annual;2020

4. Safety and efficacy of turoctocog alfa in the prevention and treatment of bleeds in previously untreated paediatric patients with severe haemophilia A: Results from the guardian 4 multinational clinical trial;Haemophilia;2019-12-09

5. Correction to: Inhibitor development, safety, and efficacy of Advate® in previously untreated patients with hemophilia A in a postmarketing surveillance in Japan;International Journal of Hematology;2018-12-17